ClinicalTrials.govpublic full text
GRACE: A Phase 1/2a Study of VTRU200 in Relapsed/Refractory AML, High-risk MDS, DLBCL Post CART Failure and Advanced Solid Tumors
acute myeloid leukemia, diffuse large b cell lymphoma (dlbcl), high risk myelodysplastic syndrome, solid tumor malignancies, pediatric acute myeloid leukemia
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 633715
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.